International Immunology Advance Access originally published online on January 31, 2005
International Immunology 2005 17(3):325-333; doi:10.1093/intimm/dxh212
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS
1 Department of Anatomy and Cell Biology, Institute of Biomedical Science and 2 Department of Microbiology, College of Medicine, Hanyang University, Seoul 133-791, Korea
Correspondence to: J. Youn; E-mail: jhyoun{at}hanyang.ac.kr
Although bacterial LPS has been used to boost the susceptibility to antibody-induced arthritis, the mechanism of the action of LPS remains to be clarified. We investigated whether signals triggered by Toll-like receptor (TLR)-4 mediate the effects of LPS in the context of anti-type II collagen-induced arthritis. The mice defective in the Tlr-4 gene (Tlr-4lps-d) were markedly less susceptible than wild type to arthritis, as manifested in arthritic index, incidence and synovitis. Levels of the pro-inflammatory mediators, tumor necrosis factor-
and cyclooxygenase-2, in their synovial tissue were also much lower. Serum C3 deposition through the alternative pathway and de novo synthesis of C3 were lower in the Tlr-4lps-d mice in the post-acute phase, pointing to an influence of TLR-4 signals on the turnover rate of complement cascades. T cells from the Tlr-4lps-d mice failed to proliferate in response to an auto-antigen, glucose-6-phosphate isomerase (GPI), unlike those from wild-type mice, and the serum level of GPI-specific IgG antibody was significantly lower than in the wild-type mice. Interestingly, type 2 responses, such as GPI-specific IgG1 and IL-4 production, were up-regulated in the Tlr-4lps-d mice. Taken together, our data suggest that the TLR-4 signaling pathway plays an essential role in the initiation and progression of auto-antibody/LPS-triggered arthritis by inducing pro-inflammatory mediators, C3 deposition, auto-antigen-specific adaptive immune responses and immune deviation between type 1 and type 2 responses.
Keywords: antibody-induced arthritis, LPS, Th1/Th2, Toll-like receptor-4, type II collagen
Transmitting editor: K. Yamamoto
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Harama, K. Koyama, M. Mukai, N. Shimokawa, M. Miyata, Y. Nakamura, Y. Ohnuma, H. Ogawa, S. Matsuoka, A. W. Paton, et al. A Subcytotoxic Dose of Subtilase Cytotoxin Prevents Lipopolysaccharide-Induced Inflammatory Responses, Depending on its Capacity to Induce the Unfolded Protein Response J. Immunol., July 15, 2009; 183(2): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Hultqvist, K S Nandakumar, U Bjorklund, and R Holmdahl The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders Ann Rheum Dis, January 1, 2009; 68(1): 130 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Salojin and T. Oravecz Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes J. Leukoc. Biol., April 1, 2007; 81(4): 860 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Roelofs, W. C. Boelens, L. A. B. Joosten, S. Abdollahi-Roodsaz, J. Geurts, L. U. Wunderink, B. W. Schreurs, W. B. van den Berg, and T. R. D. J. Radstake Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis. J. Immunol., June 1, 2006; 176(11): 7021 - 7027. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nozaki, B. J. Raisler, E. Sakurai, J. V. Sarma, S. R. Barnum, J. D. Lambris, Y. Chen, K. Zhang, B. K. Ambati, J. Z. Baffi, et al. Drusen complement components C3a and C5a promote choroidal neovascularization PNAS, February 14, 2006; 103(7): 2328 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Salojin, I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses J. Immunol., February 1, 2006; 176(3): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||



